BAG3 regulates multiple myeloma cell proliferation through FOXM1/Rb/E2F axis

Upregulation of FOXM1 in a subset of relapsed myeloma results in poor outcome

(2018) Chunyan Gu et al.   Blood Cancer Journal

Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma

(2016) N. Weinhold et al.   BLOOD

Breaking BAG: The Co-Chaperone BAG3 in Health and Disease

(2016) Christian Behl   TRENDS IN PHARMACOLOGICAL SCIENCES

FOXM1 is a therapeutic target for high-risk multiple myeloma

(2015) C Gu et al.   LEUKEMIA

Validation of the Hsp70-Bag3 Protein-Protein Interaction as a Potential Therapeutic Target in Cancer

(2015) X. Li et al.   MOLECULAR CANCER THERAPEUTICS

Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back

(2014) Giada Bianchi et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Hsp70–Bag3 Interactions Regulate Cancer-Related Signaling Networks

(2014) Teresa A. Colvin et al.   CANCER RESEARCH

Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma

(2010) D. Hose et al.   HAEMATOLOGICA

IKK  protein is a target of BAG3 regulatory activity in human tumor growth

(2010) M. Ammirante et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Transcriptional upregulation of BAG3 upon proteasome inhibition

(2007) Hua-Qin Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS